The 86th API China:

All rights reserved ©  Reed Sinopharm Exhibitions Co., Ltd.    京ICP备06050757号                                                                                    Website building:Powered By Beijing

International Sales and marketing:

Evan Wang 010-84556692



About us

  Reed Sinopharm Exhibitions LLC ("Reed Sinopharm") is an exhibition and conference organizer specializing in Chinese medicine and health. It is a member of China National Pharmaceutical Group Corporation and Reed Exhibitions Group.

  Reed Sinopharm's scope of business involves the host, host the national pharmaceuticals, APIs, medical devices, chemical reagents, analytical instruments, glassware, laboratory equipment, pharmaceutical equipment, packaging materials, Chinese herbal medicines, health products, cosmetics raw materials and pharmaceutical industry related Technologies and services, exchanging conferences, fairs, domestic and international academic seminars and related conference services; going abroad to hold economic and trade exhibitions and holding foreign economic and technological exhibitions in China.

  Reed Sinopharm adhering to the "service industry-wide, and seek common development" business philosophy, is committed to building business and academic integration of an effective platform for its professional exhibition team, informative huge information resources and improve the service system to attract the industry almost All leading enterprises, businessmen, research institutes and professionals come to attend a dozen professional exhibitions and conferences held annually. Reed Sinopharm is committed to continuous innovation and development of new projects to meet the needs of the market and promote the prosperity of the industry. All the brands under the company have become the most effective business platform for displaying the corporate image, exchanging information, developing domestic and foreign markets, promoting trade and industrial progress in the fields of pharmaceuticals, medical devices, industrial and commercial enterprises, research institutes and medical service fields, and effectively promoted Exchanges with overseas pharmaceutical industry.